Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Biosearch Technologies, Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NX7NLJUNSEU6
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Under this grant we propose to continue
the development and application of a new class of fluorescence quenched probes
with optimized features for genetic analysis and quantitation. The enhanced
performance of our novel probes is by virtue of a set of high performance dark
quenchers we refer to as "Black Hole Quenchers," or BHQs. The BHQ quenchers
have been designed to optimize quenching by two independent modes, 1) formation
of a ground state complex between the fluorophore and quencher leading to
quenching by non-FRET mechanism, and 2) maximize spectral overlap between the
fluorophore emission and quencher absorption to maximize FRET quenching, We
have prepared a set of three quenchers to provide effective quenching from 480
nm to 720 nm. BHQ probes will have several desirable features which
differentiate them from currently available probes. First, BHQ probes have
extraordinarily low spurious noise (ie no non-specific reporter signal) and
thus have a very high signal to noise ratio (S/N). This property will result in
enhanced sensitivity and lower detection thresholds when compared with
currently available probes, thus fewer copies of gene targets will be
detectable. Secondly, BHQ probes will be more readily purified than
conventional FRET probes and thus will be more cost effective to manufacture.
Since BHQs are "dark" quenchers they expand the available bandwidth thus
allowing the multiplexing of several different probes at once. BHQ quenchers
will improve the performance of virtually all FRET probe mediated assays,
including Taqman, Molecular Beacons, Sunrise Scorpions, and Invader.
PROPOSED COMMERCIAL APPLICATION:
Self-quenching fluorogenic oligonucleotide probes have become important tools for the detection, quantitation, and discrimination of genetic matter. However current probe designs are difficult and expensive to prepare and often have extraneous noise which limits their usefulness. The new class of probes proposed here will be more economically manufactured and will have very low noise. It is estimated that probe cost will diminish from the current average of $400 per probe to less than $100 per probe, thus opening quenched probes to entirely new applications and markets.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
24 SBIR/STTR records share this UEI (1987–2010). Reported award amounts total $6,757,218. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards